HAT1 Emerges as a Driver of Glioblastoma Growth and Drug Sensitivity
A multi-omics study identifies the epigenetic regulator HAT1 as upregulated in glioblastoma, where its inhibition slows tumor growth and boosts ...
A multi-omics study identifies the epigenetic regulator HAT1 as upregulated in glioblastoma, where its inhibition slows tumor growth and boosts ...
A preclinical study reports that the MEK inhibitor cobimetinib suppressed MAPK signaling, tumor cell invasion and immune-evasive features in anaplastic ...
A study of breast tissue microarrays mapped where regulatory RNAs and stromal proteins sit within benign, DCIS and invasive lesions, ...
A new review explains how regulatory T cells are co-opted by ovarian tumors to suppress immunity, and how precision therapies ...
A computational analysis of single-cell RNA sequencing data maps 208 prognosis-linked miRNA-target pairs carried by extracellular vesicles in the hepatocellular ...
A retrospective study of 83 men with metastatic hormone-sensitive prostate cancer found that Hispanic American patients presented with more advanced ...
A new review finds that CT-derived extracellular volume fraction correlates with fibrosis, tumor biology, prognosis, and treatment response across abdominal ...
A three-gene signature linked to tumor purity stratifies pancreatic adenocarcinoma patients by survival and reveals differences in CD8-positive T-cell activation.
A machine learning model built from single-cell data stratifies osteosarcoma patients by survival risk and identifies OPN3 as a candidate ...
Preclinical research shows that blocking the aryl hydrocarbon receptor reshapes myeloid–T cell crosstalk and enhances anti-PD-1 responses across mouse and ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine